These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12955427)

  • 21. A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
    Chen YD; Lu YL; Jin ZN; Yuan F; Lü SZ
    Chin Med J (Engl); 2006 Mar; 119(5):360-6. PubMed ID: 16542577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized comparison of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, versus aspirin in prevention of angiographic restenosis after coronary artery Palmaz-Schatz stent implantation.
    Galassi AR; Tamburino C; Nicosia A; Russo G; Grassi R; Monaco A; Giuffrida G
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):162-8. PubMed ID: 10348536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up.
    Piamsomboon C; Laothavorn P; Chatlaong B; Saguanwong S; Nasawadi C; Tanprasert P; Leelaprute M; Intayakorn U; Amornsak N
    J Med Assoc Thai; 2001 Dec; 84(12):1701-7. PubMed ID: 11999816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
    Perez G; Rodriguez-Granillo AM; Mieres J; Llaurado C; Rubilar B; Risau G; Fernandez-Pereira C; Rodriguez AE
    J Invasive Cardiol; 2009 Aug; 21(8):378-82. PubMed ID: 19652248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
    J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
    Eisenstein EL; Anstrom KJ; Kong DF; Shaw LK; Tuttle RH; Mark DB; Kramer JM; Harrington RA; Matchar DB; Kandzari DE; Peterson ED; Schulman KA; Califf RM
    JAMA; 2007 Jan; 297(2):159-68. PubMed ID: 17148711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of cilostazol and clopidogrel after successful coronary stenting.
    Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
    Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of restenting should be minimized with intracoronary radiation therapy for in-stent restenosis.
    Cha DH; Malik IA; Cheneau E; Ajani AE; Leborgne L; Wolfram R; Porrazzo M; Satler LF; Kent KM; Pichard AD; Pinnow E; Lindsay J; Waksman R
    Catheter Cardiovasc Interv; 2003 May; 59(1):1-5. PubMed ID: 12720231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
    Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ
    Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.
    Popma JJ; Leon MB; Moses JW; Holmes DR; Cox N; Fitzpatrick M; Douglas J; Lambert C; Mooney M; Yakubov S; Kuntz RE;
    Circulation; 2004 Dec; 110(25):3773-80. PubMed ID: 15596568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
    Gwon HC; Hahn JY; Park KW; Song YB; Chae IH; Lim DS; Han KR; Choi JH; Choi SH; Kang HJ; Koo BK; Ahn T; Yoon JH; Jeong MH; Hong TJ; Chung WY; Choi YJ; Hur SH; Kwon HM; Jeon DW; Kim BO; Park SH; Lee NH; Jeon HK; Jang Y; Kim HS
    Circulation; 2012 Jan; 125(3):505-13. PubMed ID: 22179532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
    Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
    Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation.
    Juergens CP; Wong AM; Leung DY; Lowe HC; Lo S; Fernandes C; Newland EF; Hopkins AP
    Am Heart J; 2004 Apr; 147(4):E15. PubMed ID: 15077098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.
    Schulz S; Sibbing D; Braun S; Morath T; Mehilli J; Massberg S; Byrne RA; Schömig A; Kastrati A
    Am Heart J; 2010 Aug; 160(2):355-61. PubMed ID: 20691843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial.
    Brener SJ; Steinhubl SR; Berger PB; Brennan DM; Topol EJ;
    J Invasive Cardiol; 2007 Jul; 19(7):287-90. PubMed ID: 17620671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.